Načítá se...
CYP2C19 genetic variation and individualized clopidogrel prescription in a cardiology clinic
Background: Clopidogrel (Plavix) is an antiplatelet medication that is routinely used in patients with cardiovascular disease. Cytochrome P2C19 enzymes play a major role in its metabolism, which determines its varied therapeutic level and its effectiveness. Objectives: To customize clopidogrel thera...
Uloženo v:
| Vydáno v: | J Community Hosp Intern Med Perspect |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5538219/ https://ncbi.nlm.nih.gov/pubmed/28808507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2017.1347475 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|